The Application of Electrical Stimulation in Postoperative Pain Management of Thyroid Surgery
Launched by XIAONAN HUANG · Apr 9, 2025
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Project Research Objectives:
1. Explore Innovative Analgesic Management Schemes after Thyroidectomy Through clinical trials and data analysis, evaluate the efficacy and safety of the wrist-ankle electrical stimulation analgesia device in post-thyroidectomy analgesia management. Explore more scientific, reasonable, and effective postoperative analgesia management schemes to provide theoretical basis and empirical support for clinical practice and promote the development and progress of pain management.
2. Achieve Remote Monitoring and Artificial Intelligence Application In the future, it wi...
Gender
ALL
Eligibility criteria
- 1. Inclusion Criteria:
- • Be over 18 years of age;
- • The operation time is less than 4 hours;
- • Postoperative VAS pain score ≥3 points ;
- • Clear consciousness, able to answer questions accurately, free speech, no hearing impairment;
- • Informed consent
- 2. Exclusion Criteria:
- • Neck or thyroid surgery within the past ten years;
- • Menstruating, pregnant and lactating females;Those who are not satisfied with blood glucose control;
- • Skin injury or allergy; skin ulceration;
- • Past history of psychiatric disorder that met the diagnostic criteria of Diagnostic and Manual of Mental Disorders, DSM-IV;
- • Upper respiratory tract infection within 2 weeks before surgery;
- • History of implantation of pace or defibrillator;
- • Allergic to gel or intolerant to electrical stimulation;
- • History of chronic pain, pain VAS score 1 at the examination;
- • Use of sedative analgesic drugs for a long time or within 24 hours;
- • Particip in other clinical trials in the past 4 weeks.
About Xiaonan Huang
Xiaonan Huang is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, Xiaonan leads initiatives that prioritize rigorous methodology and ethical standards in clinical trials. By fostering collaborations with healthcare professionals and research institutions, Xiaonan aims to facilitate the development of safe and effective treatments across various medical fields. Their expertise in clinical operations and regulatory compliance ensures that trials are conducted efficiently and transparently, ultimately contributing to the enhancement of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Yangpu District, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported